Primary prevention of cardiovascular disease: time to get more or less personal?

JAMA. 2009 Nov 18;302(19):2144-5. doi: 10.1001/jama.2009.1698.

Authors

Aroon D Hingorani¹, Bruce M Psaty

Affiliation

¹ Genetic Epidemiology Group, Department of Epidemiology and Public Health and the Centre for Clinical Pharmacology, University College London, London, England, UK. a.hingorani@ucl.ac.uk

PMID: 19920239
DOI: 10.1001/jama.2009.1698

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cardiovascular Diseases / prevention & control*
Comparative Effectiveness Research*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Precision Medicine
Primary Prevention*
Risk Assessment

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding